More Monitoring Required of Institutional Review Boards
The Government Accountability Office has issued an analysis suggesting that the FDA should increase its oversight of institutional review boards (IRBs) to better protect...
Stroke Patients To Get A Relief With Spinal Cord Stimulation
A small clinical trial has suggested that spinal cord stimulation may help stroke patients regain movement in their limbs and hands. In an article...
Major Trial Reveals Simplified HIV Treatment Options Perfect
As per the results of international research, which has the distinction of being the world’s first study into second-line human immunodeficiency virus- HIV therapy,...
DNA Mutations Can Help Kidney Cancer Recurrence Be Assessed
One of the international studies on kidney cancer recurrence has found that physicians can forecast the likelihood of a disease returning by way of...
Could The Long Deckline In Biotechnology M&A Be Ending
There were at least 14 biopharma purchases totaling $50 million or more between April and June, which is at least twice as many as...
As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits
An innovative system for monitoring chromosomal fragility and copy number alterations in particularly lethal tumours was described earlier this July by researchers from Cambridge University...
Indian Pharma Business May Increase 8-11%, Predicts Alkem
When the epidemic subsides, Alkem Laboratories predicts that inflationary pressures and shifting regulatory standards will be the primary concerns to keep an eye on,...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...